5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 4.58▲ | 4.58▲ | 4.62▼ | 4.86▼ | 4.83▼ |
MA10 | 4.60▼ | 4.61▼ | 4.62▼ | 4.94▼ | 4.76▼ |
MA20 | 4.62▼ | 4.63▼ | 4.76▼ | 4.93▼ | 4.76▼ |
MA50 | 4.63▼ | 4.87▼ | 4.92▼ | 4.79▼ | 5.48▼ |
MA100 | 4.82▼ | 4.92▼ | 4.95▼ | 4.87▼ | 8.29▼ |
MA200 | 4.91▼ | 4.90▼ | 4.82▼ | 5.01▼ | 34.14▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.003▼ | 0.003▲ | -0.012▼ | -0.047▼ | 0.083▲ |
RSI | 45.138▼ | 39.217▼ | 36.894▼ | 40.217▼ | 44.788▼ |
STOCH | 25.333 | 19.385▼ | 32.219 | 49.811 | 59.295 |
WILL %R | -53.333 | -66.667 | -84.906▼ | -86.765▼ | -55.118 |
CCI | -85.990 | -73.697 | -70.352 | -246.668▼ | -36.637 |
Saturday, September 13, 2025 06:11 AM
Detailed price information for Precision Biosciences Inc (DTIL-Q) from The Globe and Mail including charting and trades.
|
Friday, September 12, 2025 04:18 AM
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...
|
Wednesday, September 10, 2025 01:00 AM
About VIVO ™ Catheter Precision’s VIVO (View Into Ventricular Onset), is a non-invasive 3D imaging system that enables physicians to identify the origin of ventricular arrhythmias pre-procedure, ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/09/25 | 4.66 | 4.67 | 4.52 | 4.59 | 48,905 |
12/09/25 | 4.85 | 4.9664 | 4.50 | 4.61 | 368,830 |
11/09/25 | 5.02 | 5.10 | 4.91 | 5.00 | 45,246 |
10/09/25 | 5.14 | 5.14 | 4.90 | 5.01 | 45,646 |
09/09/25 | 4.91 | 5.14 | 4.8625 | 5.09 | 37,533 |
08/09/25 | 5.07 | 5.07 | 4.86 | 4.97 | 52,195 |
05/09/25 | 4.93 | 5.17 | 4.9244 | 5.07 | 68,619 |
04/09/25 | 5.04 | 5.05 | 4.892 | 5.03 | 34,230 |
03/09/25 | 4.95 | 5.1152 | 4.95 | 5.05 | 59,884 |
02/09/25 | 4.83 | 5.01 | 4.70 | 5.00 | 116,200 |
|
|
||||
|
|
||||
|
|